Spero Therapeutics Announces Exercise of $15.9 Million Option by BARDA for Tebipenem HBr Development - BioSpace Get link Facebook X Pinterest Email Other Apps - February 06, 2020 Spero Therapeutics Announces Exercise of $15.9 Million Option by BARDA for Tebipenem HBr Development BioSpace Get link Facebook X Pinterest Email Other Apps Comments
Comments
Post a Comment